Case Report: Stevens-Johnson Syndrome and Hepatotoxicity Induced by Osimertinib Sequential to Pembrolizumab in a Patient With EGFR-Mutated Lung Adenocarcinoma

Background: Lung cancer is a complex disease with many subtypes. However, histochemical characteristics, and genetic mutation determinations are contributing to better define therapeutic targets and new drugs. Although this guarantees patients the possibility of obtaining tailored treatment, it make...

Descripción completa

Detalles Bibliográficos
Autores principales: Gianni, Caterina, Bronte, Giuseppe, Delmonte, Angelo, Burgio, Marco Angelo, Andrikou, Kalliopi, Monti, Manlio, Menna, Cecilia, Frassineti, Giovanni Luca, Crinò, Lucio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397522/
https://www.ncbi.nlm.nih.gov/pubmed/34456717
http://dx.doi.org/10.3389/fphar.2021.672233

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397522/
https://www.ncbi.nlm.nih.gov/pubmed/34456717
http://dx.doi.org/10.3389/fphar.2021.672233

Ejemplares similares